Type your tag names separated by a space and hit enter

Letermovir

Kathryn Dzintars, Pharm.D., BCPS
Letermovir is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

Pediatrics Central

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Prophlyaxis of cytomegalovirus infection (CMV) in patients (> 18 years of age) who are CMV-seropositive and have undergone an allogeneic stem cell transplant

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: June 6, 2018

Citation

Dzintars, Kathryn. "Letermovir." Johns Hopkins ABX Guide, The Johns Hopkins University, 2018. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540691/all/Letermovir.
Dzintars K. Letermovir. Johns Hopkins ABX Guide. The Johns Hopkins University; 2018. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540691/all/Letermovir. Accessed April 19, 2019.
Dzintars, K. (2018). Letermovir. In Johns Hopkins ABX Guide. Available from https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540691/all/Letermovir
Dzintars K. Letermovir [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2018. [cited 2019 April 19]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540691/all/Letermovir.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Letermovir ID - 540691 A1 - Dzintars,Kathryn,Pharm.D., BCPS Y1 - 2018/06/06/ BT - Johns Hopkins ABX Guide UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540691/all/Letermovir PB - The Johns Hopkins University DB - Pediatrics Central DP - Unbound Medicine ER -